Follow
khashayar
khashayar
Biomedical Researcher
Verified email at bondagroup.com
Title
Cited by
Cited by
Year
Next steps toward eradication of hepatitis C in the era of direct acting antivirals
K Hesamizadeh, H Sharafi, MS Rezaee-Zavareh, B Behnava, SM Alavian
Hepatitis monthly 16 (4), 2016
832016
Recommendations for the clinical management of hepatitis C in Iran: a consensus-based national guideline
SM Alavian, B Hajarizadeh, KB Lankarani, H Sharafi, NE Daryani, S Merat, ...
Hepatitis monthly 16 (8), 2016
692016
Hepatitis A virus and hepatitis E virus seroprevalence among blood donors in Tehran, Iran
K Hesamizadeh, H Sharafi, H Keyvani, SM Alavian, ANT Shabankareh, ...
Hepatitis monthly 16 (1), 2016
422016
Combination of ledipasvir and sofosbuvir for treatment of hepatitis C virus genotype 1 infection: systematic review and meta-analysis
MS Rezaee-Zavareh, K Hesamizadeh, B Behnava, SM Alavian, ...
Annals of Hepatology 16 (2), 188-197, 2017
332017
A possible pathogenic correlation between neutrophil elastase (NE) enzyme and inflammation in the pathogenesis of coronavirus disease 2019 (COVID-19)
S Karampoor, K Hesamizadeh, F Maleki, M Farahmand, H Zahednasab, ...
International Immunopharmacology 100, 108137, 2021
282021
Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection
F Bokharaei‐Salim, H Keyvani, M Esghaei, S Zare‐Karizi, ...
Journal of medical virology 88 (11), 1960-1966, 2016
252016
The role of lovastatin in the attenuation of COVID-19
S Karampoor, K Hesamizadeh, Z Shams, AG Novin, M Farahmand, ...
International Immunopharmacology 101, 108192, 2021
172021
Incorporation of the tat cell‐penetrating peptide into nanofibers improves the respective antitumor immune response
M Mohammadi, P Dehghani, A Mohseninia, M Roozbehani, A Hemphill, ...
Journal of cellular physiology 236 (2), 1401-1417, 2021
132021
Molecular epidemiology of Kaposi’s sarcoma-associated herpes virus, and risk factors in HIV-infected patients in Tehran, 2014
K Hesamizadeh, H Keyvani, F Bokharaei-Salim, SH Monavari, M Esghaei, ...
Iranian Red Crescent Medical Journal 18 (11), 2016
122016
Molecular tracing of hepatitis c virus genotype 1 isolates in iran: a NS5B phylogenetic analysis with systematic review
K Hesamizadeh, SM Alavian, ANT Shabankareh, H Sharafi
Hepatitis Monthly 16 (12), 2016
92016
Genetically engineered fusion of allergen and viral-like particle induces a more effective allergen-specific immune response than a combination of them
MZ Sani, A Bargahi, N Momenzadeh, P Dehghani, MV Moghadam, ...
Applied Microbiology and Biotechnology 105, 77-91, 2021
72021
Treatment of hepatitis C infection with direct-acting antiviral agents in liver-transplant patients: a systematic review and meta-analysis
MS Rezaee-Zavareh, K Hesamizadeh, H Sharafi, SM Alavian
Hepatitis Monthly 17 (6), 11, 2017
7*2017
Peg-interferon plus ribavirin combination therapy in HCV mono-infected and HCV/HIV co-infected patients in Iran
K Hesamizadeh, A Tavakoli, M Nikbin
Medical journal of the Islamic Republic of Iran 33, 63, 2019
62019
Photothermic therapy with cuttlefish ink-based nanoparticles in combination with anti-OX40 mAb achieve remission of triple-negative breast cancer
N Momenzadeh, S Hajian, A Shabankare, R Ghavimi, S Kabiri-Samani, ...
International Immunopharmacology 115, 109622, 2023
42023
False-negative results in taqman one-step rt-pcr test: Evaluation of endogenous internal control function used in sars-cov-2 detection tests
H Choobin, S Asiyabi, K Hesamizadeh, T Bamdad
Jundishapur Journal of Microbiology 14 (5), 2021
2021
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline
B Hajarizadeh, KB Lankarani, H Sharafi, NE Daryani, S Merat, M Mohraz, ...
Brieflands, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–16